# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA655779 | B | In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrate | 100 | ALA1134488 | single protein format | Scientific Literature | ||
2. | ALA812180 | F | Cytotoxicity measured against human T-cells | Homo sapiens | 90 | ALA1134488 | cell-based format | Scientific Literature | |
3. | ALA812183 | F | In vitro inhibition of human T-cell proliferation | Homo sapiens | 97 | ALA1134488 | cell-based format | Scientific Literature | |
4. | ALA3301363 | P | ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5 | 4,197 | ALA3301361 | small-molecule physicochemical format | AstraZeneca Deposited Data | ||
5. | ALA4418534 | B | Binding affinity to S100A4 (unknown origin) assessed as inhibition of S100A4/myosin-2A interaction using fluorescein-tagged myosin-2A peptide (1908 to 1923 residues) by fluorescence polarization assay | Homo sapiens | 54 | ALA4418481 | single protein format | Patent Bioactivity Data | |
6. | ALA4418538 | F | Induction of cell death in human MDA-MB-231 cells at 100 uM incubated for 24 hrs by MTT assay relative to untreated control | Homo sapiens | 1 | ALA4418481 | cell-based format | Patent Bioactivity Data |